The projected annual revenue for ACADIA Pharmaceuticals is 827MM, a decrease of 11.02%. The projected annual non-GAAP EPS is ...
Barwa's board of directors has proposed the distribution of a cash dividend of 18% of the shares’ par value at the rate of ...